Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

IBM Shares Gain as Jefferies Highlights Undervalued Software Potential

Felix Baarz by Felix Baarz
January 7, 2026
in Analysis, Tech & Software, Turnaround, Value & Growth
0
IBM Stock
0
SHARES
76
VIEWS
Share on FacebookShare on Twitter

A recent upgrade from Jefferies Financial Group has provided fresh momentum for International Business Machines Corp. (IBM), with the stock trading near its 52-week high. The firm’s analysts point to a significant re-rating opportunity within IBM’s software division, though traditional valuation metrics suggest investors should temper their enthusiasm.

Valuation Discount Presents Opportunity, Jefferies Argues

In a move that has captured market attention, Jefferies upgraded IBM from “Hold” to “Buy” on January 6. Analyst Brent Thill also raised the firm’s price target substantially, from $300 to $360 per share. This new target suggests an approximate 20% upside from the previous closing price of $302.23.

The core of Jefferies’ bullish thesis rests on an anticipated acceleration in IBM’s software revenue by 2026. The analysts highlight several key growth drivers they believe the market is undervaluing:
* Red Hat’s Momentum: Continued strength in the hybrid cloud platform segment.
* Strategic Acquisitions: Potential synergies from the integration of HashiCorp and the planned deal with Confluent.
* Stable Foundation: Reliable, recurring revenue from the legacy mainframe business.

A central argument for investment is IBM’s current valuation discount relative to large-cap software peers. Jefferies estimates a 2027 price-to-earnings (P/E) ratio of 26 for IBM, which sits below the sector average of approximately 35. This perspective has found some agreement elsewhere on Wall Street; RBC Capital increased its target to $350, while Stifel Nicolaus set a $325 target.

Should investors sell immediately? Or is it worth buying IBM?

Strong Operational Performance Fuels Confidence

The optimistic analyst outlook is supported by demonstrable operational strength. IBM’s recent extension of its partnership with The Wimbledon Championships as the official technology partner reinforces its competitive positioning in the enterprise AI solutions market.

The rally is fundamentally underpinned by robust third-quarter results. The company reported earnings per share of $2.65, surpassing estimates by $0.20. Year-over-year revenue climbed 9.1% to $16.33 billion. This solid operational execution has bolstered investor confidence, reflected in a share price gain of nearly 40% over the past twelve months.

Lofty Expectations Warrant Investor Caution

Despite the analyst enthusiasm, IBM’s shares are no longer trading at a bargain basement price. The stock currently commands a P/E ratio above 36. Furthermore, a price/earnings-to-growth (PEG) ratio of 2.70 indicates a rich valuation by historical standards, especially when compared to a lower industry average. Investors are presently paying a premium for expected future growth, which narrows the margin for error if performance disappoints.

The next critical test will arrive on January 28, 2026, when IBM discloses its full-year results. Market experts are forecasting annual earnings per share of $10.78. Whether the stock can achieve Jefferies’ elevated price target will depend heavily on the company’s ability to meet these high expectations.

Ad

IBM Stock: Buy or Sell?! New IBM Analysis from November 5 delivers the answer:

The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

IBM: Buy or sell? Read more here...

Tags: IBM
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Apex Critical Metals Stock

Apex Critical Metals Secures Key Permit, Paving Way for Drilling Campaign

MP Materials Stock

MP Materials Stock Surges on Unprecedented Trading Activity and Strategic Deals

Lynas Stock

Lynas Shares Rally on Geopolitical Tensions and Price Stabilization Hopes

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com